These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24386307)

  • 1. Ubiquitination increases parkin activity to promote autophagic α-synuclein clearance.
    Lonskaya I; Desforges NM; Hebron ML; Moussa CE
    PLoS One; 2013; 8(12):e83914. PubMed ID: 24386307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance.
    Lonskaya I; Hebron ML; Desforges NM; Schachter JB; Moussa CE
    J Mol Med (Berl); 2014 Apr; 92(4):373-86. PubMed ID: 24337465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.
    Lo Bianco C; Schneider BL; Bauer M; Sajadi A; Brice A; Iwatsubo T; Aebischer P
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17510-5. PubMed ID: 15576511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson's disease.
    Lonskaya I; Hebron ML; Algarzae NK; Desforges N; Moussa CE
    Neuroscience; 2013 Mar; 232():90-105. PubMed ID: 23262240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson's Disease Etiopathology.
    Wilkaniec A; Lenkiewicz AM; Czapski GA; Jęśko HM; Hilgier W; Brodzik R; Gąssowska-Dobrowolska M; Culmsee C; Adamczyk A
    Mol Neurobiol; 2019 Jan; 56(1):125-140. PubMed ID: 29681024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
    von Coelln R; Thomas B; Andrabi SA; Lim KL; Savitt JM; Saffary R; Stirling W; Bruno K; Hess EJ; Lee MK; Dawson VL; Dawson TM
    J Neurosci; 2006 Apr; 26(14):3685-96. PubMed ID: 16597723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
    Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin and defective ubiquitination in Parkinson's disease.
    Dawson TM
    J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation.
    Xiong H; Wang D; Chen L; Choo YS; Ma H; Tang C; Xia K; Jiang W; Ronai Z; Zhuang X; Zhang Z
    J Clin Invest; 2009 Mar; 119(3):650-60. PubMed ID: 19229105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration.
    Van Rompuy AS; Oliveras-Salvá M; Van der Perren A; Corti O; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2015 Jun; 10():23. PubMed ID: 26099628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies.
    Liu X; Hebron M; Shi W; Lonskaya I; Moussa CE
    Hum Mol Genet; 2019 Feb; 28(4):548-560. PubMed ID: 30329047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
    Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
    J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
    Ko HS; Lee Y; Shin JH; Karuppagounder SS; Gadad BS; Koleske AJ; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
    Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16691-6. PubMed ID: 20823226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease.
    Cha SH; Choi YR; Heo CH; Kang SJ; Joe EH; Jou I; Kim HM; Park SM
    Mol Neurodegener; 2015 Dec; 10():63. PubMed ID: 26627850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease.
    Kawahara K; Hashimoto M; Bar-On P; Ho GJ; Crews L; Mizuno H; Rockenstein E; Imam SZ; Masliah E
    J Biol Chem; 2008 Mar; 283(11):6979-87. PubMed ID: 18195004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease.
    Engelender S
    Autophagy; 2008 Apr; 4(3):372-4. PubMed ID: 18216494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson's disease.
    Fukae J; Sato S; Shiba K; Sato K; Mori H; Sharp PA; Mizuno Y; Hattori N
    FEBS Lett; 2009 Feb; 583(3):521-5. PubMed ID: 19146857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between Parkin and
    Madsen DA; Schmidt SI; Blaabjerg M; Meyer M
    Cells; 2021 Jan; 10(2):. PubMed ID: 33572534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.